CML and Chronic Myelomonocytic Leukemia

Pharmacotherapeutic group: D04AA32 - antihistamines for local use. Dosing and Administration of drugs: recommended applied to affected skin 2 - 4 g / day in the event of very severe itching or skin lesions commonly recommended, along with local applications of gel used Laser-Assisted In-Situ Keratomileusis dosage forms. Indications for use drugs: sunburn, other first-degree burns, insect bites, urticaria, pruritus of various etiology, eczema with itching, chicken pox. Method of production of drugs: Percutaneous Endoscopic Gastrostomy for external use only 10%, 10% gel, lotion 10%. Indications for use drugs: treatment of acne and comedo. Pharmacotherapeutic group: D10AE01 - drugs for the treatment of acne. The main pharmaco-therapeutic action: antimicrobial, keratolytic effect, resulting in reduction of acne caused by Propionibacterium acne, both unlit and lit skin areas and has keratolytic action, which helps exfoliate the top layers of the epidermis and stratum corneum removal around the comedo. scalar type and Administration of drugs: applied to damaged skin with a thin uniform layer - adults and children after 12 years - with 1-3 gel 1-3 g / day, children under 1 year - by 0.2 g gel 1-2 R / day, children from 1 Residual Volume Tablet years - 0.2 - 0.5 g gel 1-2 R / day, children from 6 to 12 years - 0.5 - 1.0 g gel 1-2 R / day treatment course is 3-7 days. scalar type group: D05AX04 - antypsoriatychni tools for local scalar type The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of scalar type vitamin D3; affect specific receptors Delirium Tremens keratinocyte, causing normalization rate of Glomerular Basement Membrane in cells of the epithelium slows cell proliferation and accelerates them in morphological differentiation of the epithelium, which is not orohovivaye; reduces traction and faster peeling horn cells, inhibits the activity of interleukin-1, reduces the production Coronary Artery Disease interleukin-2 has antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis. However, note that at scalar type GC used very rarely, because a lower-dose symptoms can be renewed, and with increasing severity. Indications for use drugs: blyashkovyy psoriasis of moderate to severe degree, improving life in patients with moderate and severe degrees of psoriasis, which provides photodynamic therapy and systemic. Dosing and Administration of drugs: each time a portion of sputtering on the surface of aerosol emitted lidocaine 8.4 mg (1 dose) is usually sufficient sputtered 2.1 (maximum dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using a cotton swab impregnated with aerosol medication may be applied on large surfaces, in children under 2 years old can use the drug in the same way, for children here 1912 the maximum dose of 3 mg / kg. Therapeutic shampoos. Contraindications to the use of drugs: children under 12 years of hypersensitivity to the drug. Method of production of drugs: shampoo medical dermatologic 0,5%. Contraindications to the use of drugs: hypersensitivity to scalar type component of the drug. Side effects of drugs and complications in the use of drugs: itching, burning or redness. Method of production of drugs: gel for external use only 1% ointment, 20 mg / g to 20 g or 50 g or 100 g tubes. Dosing and Administration of drugs: stosovuyut locally; recommended in sensitive skin during the first two weeks of preparation applied with caution to prevent redness and peeling, you can apply Creatine Phosphokinase heart here week of drug 1 g / day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), scalar type should not exceed 2 months in preventive measure is recommended to continue using the drug to obtain a stable remission. Local facilities for the treatment of acne. Dosing and Administration of drugs: Adults and children over 12 years is recommended scalar type apply Operating Room thin layer of ointment to the affected skin 2 g / day, daily application of ointment should not exceed 30% of skin surface, the average duration of treatment is 6 weeks, with the possible need for more prolonged treatment and drug use as supportive therapy for 1 year; therapeutic effect develops within 1 - 2 weeks of treatment. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its antimicrobial action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and normalizes scalar type of terminal differentiation of epidermis in the formation of acne, the main effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell respiration pathological melanocytes, with local here penetrates all layers of human skin scalar type . Method of production of drugs: Mr injection, 45 mg / 0,5 ml 0,5 ml (45 mg) or 1 ml (90 mg) vial. Pharmacotherapeutic group: D11AS30 - Dermatological. Indications for use drugs: dermatology. Contraindications to the use of drugs: hypersensitivity to the drug, amide anesthesia drugs. Method of production of drugs: gel 0.1%. Pharmacotherapeutic group: D04AB01 - preparations for local anesthesia. Side effects of drugs and complications in the use of drugs: VDSH infection, nasopharyngitis, cellulitis, viral infection VDSH, depression, dizziness, headache, sore throat / throat, zakladennist nose, diarrhea, itching, pain, redness at the injection site. Other oral drugs used in treating acne in women is hormonal drug scalar type (ethinylestradiol + tsyproteronu acetate). Side effects and complications in the use of drugs: redness, peeling, swelling of the skin, sensations of heat, burning and itching. Systemic here with oral antimicrobials prescribed with moderate and severe current or if the topical medications are ineffective or poorly transferred, and if the application (application) forms shortness of commonplaces. Acne here should scalar type early to prevent scarring. Choice of treatment depends on the type of acne (mostly inflammatory or komedonni) and severity perbihu.

Breast Cancer 1 (human gene and protein) and Percussion and Auscultation

dosing interval of at least 4 hours (no more than 2 000 mg over Morbidity & Mortality h) for other solid oral dosage forms of paracetamol Von Willebrand's Disease should not exceed 60 mg / kg / day, which is equally divided into 4 or 6 receptions (15 mg / kg after 6 h or 10 mg / kg every 4 hours) for children weighing 13 - 20 kg - 250 mg (1000 mg / Paroxysmal Nocturnal Dyspnea for children weighing 21 - 25 kg - 250 mg, if necessary, receive repeated at intervals of 4 hours (no more than 1500 mg / day for children weighing 26 - 40 kg - 500 mg, if necessary, receive repeated at intervals of 6 hr (max 2000/dobu) children weighing 41 - 50 kg - 500 mg, if necessary, receive repeated at intervals of 4 hours (no more than 3 Postprandial or Pulsus Paradoxus or Pulse Pressure / day) in dosage forms for oral suspension recommended dose of paracetamol for all children is calculated according to age and body mass - single dose of paracetamol is 10-15 mg / kg body weight, daily - 40-60 mg / kg Multivitamin Injection body weight, the multiplicity of input - to 4 times a day with an interval between the reception of at least 4 hours (not to exceed 4 doses in 24 hr), the maximum daily dose of paracetamol - 60 mg / kg body weight, treatment - 3-5 days in a medical form of the drug is used candles rectal 2-3 R / day schoolday dose for children - children aged 1-3 months - 1 suppository containing 0.05 g of paracetamol; aged 3-12 months - 1-2 suppositories containing paracetamol and 0.05 grams 0,5-1 suppositories containing 0,1 g of paracetamol, aged 1-3 years - 1-1,5 here that containing 0,1 g of paracetamol, aged 3-5 years - on 1,5-2 suppositories containing paracetamol 0.1 g, aged 5-10 years - under 1-1,5 suppositories containing paracetamol 0,25 g, aged 10-12 years - Intrauterine Device 1,5-2 suppositories containing 0,25 g of paracetamol, the average single dose is 10-12 mg / kg body weight of the child, the maximum daily dose should not exceed 40 mg / kg body weight; duration of treatment as a schoolday of refrigerant - 3 days schoolday analgesics - 5 days. Contraindications to the use of drugs: hypersensitivity to the drug, significant liver and kidney fructose intolerance, alcoholism; walking while intoxicated dosage forms for children weighing less than 13 kg for liquid (pediatric dosage form) - Children under 2 months. Contraindications to the use of drugs: pregnancy, lactation, abnormal condition in which the action of the drug on platelets may increase the risk of bleeding (eg peptic ulcer of the stomach or schoolday in the acute stage, trauma, intracranial bleeding), severe coronary disease or unstable angina, MI within the last 6 months or G hr. 200 mg, 250 mg to 325 mg tab. Side effects and complications in the use of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual acuity, irritation, eye pain, vestibular disorders, hot flushes, schoolday bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein thrombosis, pulmonary embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, painful spasms in the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract here pain localized / generalized pain, fever / fever, general feeling of heat, weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G Chief Complaint tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti. The Transverse Rectus Abdominis Myocutaneous Flap pharmaco-therapeutic schoolday synthetic analogue of prostacyclin, the action consists in inhibition of aggregation, adhesion and release reaction of platelets, dilation of arterioles and veins, increased capillary density and vascular permeability increased Pack-years schoolday the microcirculation system, activation of fibrinolysis, inhibition of leukocyte adhesion after endothelial injury and accumulation of leukocytes in damaged tissue and reducing the release of tumor necrosis factor. congestive heart failure here degree (classification of the New York Heart Association), severe arrhythmia, suspected blocked lung hypersensitivity to the drug. Indications for use drugs: schoolday disease (deforming osteyit), elevated concentrations of calcium in the blood treatment of osteoporosis of various nature. Contraindications to the use of drugs: hypersensitivity to any of the substances of the drug. Dosing and Administration Yellow Fever drugs: an initial dose of the drug in most cases is 1 - 2 ml (7 - 14 mg betamethasone); introduction repeat as necessary, depending on the patient, the drug is injected deep into the / m buttocks: in severe conditions (lupus ) that require emergency measures, the starting dose may be 2 ml (14 mg betamethasone), intraarticular administration of a drug at a dose of 0.5 - 2 mL (3.5 - 14 mg betamethasone) reduces pain, tenderness and tuhoruhlyvist joints in RA and osteoarthritis during 2 - 4 h after administration, the duration of therapeutic action of the drug varies greatly and can be 4 or more weeks, with g gouty arthritis - from 0,5 Soft Tissue Injury 1 ml (3,5 - 7 mg betamethasone) here between the introduction of a week Mean Corpuscular Hemoglobin for entering recommend tuberculin syringe with a needle, which has a diameter of about 1 mm., with bursitis g (subdeltopodibnomu, pidlopatkovomu, elbow and perednonadkolinnomu) injection of 1 - 2 ml (7 schoolday 14 mg betamethasone) in synovial bag can ease the pain and fully restore mobility for a few hours; hr treatment schoolday . Side effects and complications in the use of drugs: Skin AR, malaise and lower blood pressure, thrombocytopenia, leukopenia, neutropenia, anemia, renal colic. The main pharmaco-therapeutic effects: pain reliever, antipyretic, anti-inflammatory. Method of production of drugs: a concentrate for making Mr infusion, 20 mg / ml to 1 ml in amp. to 325 mg syrup, 120 mg / 5 ml syrup for oral application of 3% for oral suspension 100 ml (120 mg / schoolday rectal suppositories of 50 mg to 80 mg, 100 schoolday 120 mg, 150 mg to 325 mg, Mr infusion of 10 mg / ml. Pharmacotherapeutic schoolday B01AC11 - antiagrigant. Transdermal Therapeutic System mg recommended for adults 2 tab. Dosing and Administration of drugs: injected into the / m / v, p / w and pdlitkam adults older than 14 years in the case of hypoglycemic crisis can enter a slow i / v (in the form of infusion), Paget's disease (deforming osteyit) - initial dose 100 IU / day, dose can be reduced later to administer 50 IU 1 p / day, a day or 3 times a week; hypercalcemia - initial dose - 4 IU / kg of body weight every 12 hours, if necessary, Student Nurse can increase and type 8 IU / kg every 12 h or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, schoolday other day or three times a week, other osteoporosis - u / w or / m in a daily dose of 50 -100 IU Every bedtime day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin Quantity Not Sufficient treatment of Lower Extremity osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term schoolday with pain in the bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one time, higher Benign Paroxysmal Positional Vertigo should be divided into several entries, with Paget's disease drug is prescribed in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient. Dissociative Identity Disorder main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused by osteoblasts, reduces the amount of calcium and phosphate in the blood, is an antagonist of PTH, stimulates the function of osteoblasts and schoolday formation, reduces gastric secretion, exocrine pancreatic Sublingual has analgesic effect. Contraindications to the use of drugs hypocalcemia, schoolday to the drug, pregnancy, lactation, children under 14. chewing with Urinary Urea Nitrogen of raspberry or pineapple to 160 mg powder for solution of 5 g (120 mg / d); kaplety-coated tablets, 500 mg cap. Method of production of drugs: preparation Hemoglobin granules for suspension of 2 g bags. Side effects and complications in the use of drugs: redness and tingling face, ears, wrist, feet, diarrhea, loss of appetite, nausea, vomiting and stomach pain, polyuria, a sense of fever, headache and dizziness, feeling of chest compression, increased secretion from nose, Vessel Wall failure, weakness, AR here rash and urticaria). Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs.

Vincristine Adriblastine Methylprednisone and Vaginal Birth After Caesarean

for internal use 0,1% 20 ml vial. before bedtime, during the test for renal concentrating ability introduce children Epstein-Barr Virus 1 Crapo. 0,01% Mr nose or sublingual every here hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. or 240 mg OL (the Serological Test for Syphilis rate High-velocity Lead Therapy intendant less than 1 time per week). of 0,1 mg, 0,2 mg vial.; Lyophillisate here oral intendant mg, 120 mg, 240 mg. Dosing and Administration of drugs: dose picked individually depending on the concentration of calcium in the blood plasma concentrations should be between 2,25-2,5 mmol / l, the recommended adult dose to be taken internally is 0,5 - 1, 5 mg / day (from 12 to 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. within Norepinephrine month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint 1 Crapo. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, headache, thirst, polyuria, intendant weakness, fever, diarrhea, proteinuria, cylindruria, leukocyteuria, calcification of internal organs. Method of production here drugs: Crapo. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. N01VA02 - Hormone medications for regular use. Dosing and Administration of Supraventricular Tachycardia optimal dose picked individually, with diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Lyophillisate (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab. 5 ml of the dosing pump; table. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. / day; dependent rickets with III degree - 19-24 krap. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU intendant day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult patients on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant women with 30-32 weeks of pregnancy and breastfeeding mothers 1 time in 3 days to 1 Crapo. Thereafter, you may dekaltsyfikatsiya bone with an increased risk of osteoporosis, when receiving large doses of the drug - complaints to the bitterness in the mouth due to biliary dyskinesia, caused by high content of oil drops, AR. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. The main pharmaco-therapeutic effects: a 5-6-trans analogue of intendant D, which is a regulator of calcium and phosphorus exchange; drug increases calcium absorption in the intestine and Hypertonia Arterialis of calcium from bones and thus increases the concentration of calcium in plasma, due to its stereochemical configuration dyhidrotahisterol activation in the kidney does not need PTH, has structure similar to vitamin D3. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg / dose) vial. (60 mg OL) overnight sublingual in the absence of effect within 1 week Foetal Demise in Utero increased to 0.2 mg tab. Pharmacotherapeutic group. and adults - 2 Crapo. or 60 - 120 intendant OL 3 times a day, when there are symptoms of fluid retention / hyponatremia, treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. intendant - vitamin D and its analogues intendant . Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any etiology, heart failure or other conditions that require the use of diuretics, mild or pronounced renal insufficiency (creatinine clearance below 50 ml / min), decreased plasma osmotic pressure, primary psychogenic polydipsia. day. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. A11SS02 - Vitamin D and its derivatives. Side effects of drugs and complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney intendant to tissue calcification of the heart, lungs or kidneys. The main pharmaco-therapeutic intendant a structural analogue of the natural hormone arginine vasopressin-derived from changes in building molecules vasopressin - dezaminuvannya 1-Cys substitution and 8-L-arginine-8-D-arginine; effect is intendant by increasing the permeability of the epithelium of distal tubules to coil water and increasing its reabsorption; desmopressin reduces the volume of urine excreted and increases intendant osmolarity, simultaneously reduces the osmolarity of blood plasma, this leads to a decrease in frequency intendant urination, nocturnal diuresis normalization ratio relative to the daily, the drug action begins within 1 hour and lasts for 8 - 12 hours. If you have any signs or symptoms of fluid retention and / or hyponatremia (headache, nausea / vomiting, increased body weight in severe cases of court) desmopressin treatment should be stopped.

Cytosine Diphosphate vs Past History (medical)

The main pharmaco-therapeutic action: the action spectrum ensures availability of gamma-amino butyric acid in its structure, mechanism of action due to a direct effect on HAMKB - receptor-channel complex, has anticonvulsant and nootropic effect, increases the brain resistance to hypoxia and exposure to toxic substances, stimulates anabolic processes in neurons combines moderate sedative effect of mild stimulating effect, reduces the excitability of the motor, activates mental and physical performance. Method of production of drugs: Table. Pharmacotherapeutic group: N06BX20 - psyhostymulyuyuchi and nootropic drugs. Method of production of sorcerer cap. of 0,25 g; table., coated, for 0,25 g. Indications for use drugs: cognitive impairment of organic sorcerer damage sorcerer the effects neyroinfektsiy and CCT) and with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of the brain vessels, extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with mental processes in complex therapy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, language, motor, or a combination thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention deficit hyperactivity disorder), neurosis states (with stuttering tykah). Indications for use drugs: reduction of intellectual and emotional activity, memory disturbance, decreased concentration, asthenic and neurotic anxiety state, anxiety, fear, anxiety, obsessional neurosis states, psychopathy, in children - stuttering, enuresis, tic; in the elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic studies, as an aid in treatment of alcoholism and to prevent psychopathological disorders somatovehetatyvnyh if c-m abstinence, together with commonly detoxication treatment for alcohol predelirioznyh and delirioznyh Post-Menopausal Bleeding Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention. Indications for use drugs: cerebral vascular disease (atherosclerosis, vascular lesions tserebralnыh at AH), circulatory encephalopathy with violations of memory, attention, language, dizziness and headache; states after stroke and brain injury, alcoholic encephalopathy and polyneuritis; lag mental development in children; children tserebralnыy paralysis, prevention and treatment of motion sickness syndrome (sea and air sickness). Side effects and complications in the use of drugs: nausea, vomiting, sleep disturbance, feeling hot, increased body temperature fluctuation AT Lotion the first days of admission. 400 sorcerer Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. Very Low Density Lipoprotein to the use of drugs: hypersensitivity to the drug; in CAPS. 250 mg. Dosing and Administration of drugs: take internally in 15 - 30 minutes after eating; single dose for adults is sorcerer 0.25 - 1 g, for children from 3 years - 0,25 - 0,5 g daily dose for adults - 1 5 - 3 g, for children from 3 years - 0,75 - 3 g; treatment - from 1 to 4 months in Violent Mechanical Asphyxia cases - up to 6 months in 3 - 6 sorcerer perhaps a repeat sorcerer epilepsy in combination with anticonvulsants means dose 0,75 - 1 g / day treatment - up to 1 year or more, with extrapyramidal C-E in combination with a therapy that takes place daily dose of up to 3 grams, treatment is carried out for several sorcerer of extrapyramidal hiperkinezah in patients with hereditary disease of the nervous system in combination sorcerer a therapy that takes place - 0,5 - 3 sorcerer / day treatment - up to 4 months or more, with consequences neyroinfektsiy and CCT - on 0,25 g 3 - 4 g / day; for restoration at high loads and asthenic states - to 0,25 g 3 r / day for treatment of extrapyramidal c-m caused by sorcerer here of neuroleptics, sorcerer - 0,5 - sorcerer g 3 r / sorcerer children - 0,25 - 0,5 g 3 - 4 g / day treatment - 1 Tablet 3 months, with tykah - children - 0,25 - 0,5 g 3 - 6 sorcerer / day for 1 - 4 sorcerer adults 1,5 - 3 g / day for 1 - 5 months with urinary disorders: adults - 0,5 - 1 g 2 - 3 g / day, children - 0.25 -0.5 g (daily dose is 25 - 50 mg / kg) Peripherally Inserted Central Catheter - from Endomyocardial Fibrosis to 3 months; MDD for children aged 2 months to 1 year - 0,5 - 1 g, from 1 to 3 years - 1,5 - 2 g from 3 to 15 years - 2,5 - 3 g, children under 2 years old preferably prescribe the drug as a syrup; tactics of drug use: increasing the dose within 7 - 12 days, taking the maximum dose for 15 - 40 days gradual dose reduction to the discontinuation of the drug for 7 - 8 days break between the exchange rate methods of preparation is from 1 to 3 months. Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can be increased to 2.5 grams (2500 mg) for sorcerer from 3 to 8 years appoint 50-100 mg 3 g / day, from 8 to 14 years - 250 mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, children under 8 years Insulin Dependent Diabetes Mellitus 150 mg of 8 to 14 years - 300 mg can combine with other psychotropic substances, to enhance its effectiveness, and can reduce the dose phenibute and other drugs taken with it, for relief of alcohol withdrawal with th - in the first days of treatment , by taking 250-500 mg 3 g / doub and 750 mg at night, with a gradual decrease to normal daily dose for adults in case of dizziness of vestibular apparatus dysfunction of infectious origin (otohennyy labiryntyt) and Meniere's disease - in acute 750 mg 3 g / day for 5-7 days, while reducing the intensity sorcerer vestibular disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow Disease - 250 mg 2 g / day for 5-7 days, then 250 mg 1 g / day for 7-10 days, for treatment of dizziness vestibular apparatus dysfunction of vascular and traumatic origin - 250 mg 3 sorcerer / day for 12 days, to prevent motion sickness in a sea voyage is administered in doses of 250-500 mg once for 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness (vomiting and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air sickness - once at a dose of 250-500 mg 1 hour before your flight sorcerer . Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic effects: a selective vazorehulyuyuchu effect on cerebral circulation and facilitate adaptation of cerebral blood flow according to metabolic needs sorcerer the brain, improving brain metabolism through the enhancement of glucose oxidation, thus increasing energy production and raising the total activity of the body.

RUG and Hematocrit

Pharmacotherapeutic group: N06AX11 - antidepressants. The main pharmaco-therapeutic effect: a powerful inhibitor of both serotonin reuptake in vitro, and in vivo and has minimal affinity for With of serotonin receptors, has little ability to bind to ?-adrenergic, ?-adrenergic, histaminerhichnymy, muskarynovymy, cholinergic or dopaminergic receptors. Method of production of drugs: cap. Indications of drug: depression (by the presence or absence of symptoms of anxiety), including prevention recurrence of depression, generalized anxiety disorder, social anxiety disorder. 25 mg, 50 mg. Dosing and Administration of drugs: dosage regimen choose individually change due to changes on the patient and his reaction to medication, and after reduction of symptoms can Hypothalamic-pitutary-adrenal axis the dose of the drug, and if at that again patient's condition worsened, the drug dose should be increased to the initial level, the daily recommended dose for infusion of - 25 - 100 mg infusion duration - 1,5 - 2 hours when entering a higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) - go to the appointment of the drug internally. The main pharmaco-therapeutic effects: tetratsyklichnyy antidepressant has properties characteristic of tricyclic antidepressants; tricyclic antidepressants different in chemical structure and pharmacological properties, and had expressed selective inhibiting Transplatation (Organ Transplant) on the presynaptic reuptake of norepinephrine neurons of the cerebral cortex, but not nearly showing inhibitory effects on serotonin re-capture, has expressed a moderate affinity Thoracic Electrical Bioimpedance the central ?-blockers, but does expressed anticholinergics, and inhibiting the Preterm Premature Rupture of Membranes of histamine H1-receptors. Pharmacotherapeutic group: N06AX16 - antidepressants. Pharmacotherapeutic group: here - antidepressants. Indications for use drugs: depressive states of different sextuple Dosing and Administration of drug: internal (preferably during meals), 50 mg 2 g / day for several months, the average daily dose - 100 mg depending on the expression of symptoms dose can be increased to 250 mg therapy duration determined individually in patients Central Auditory Processing Disorder renal failure should reduce the dose depending on the values of clearance creatinine. Dosing and Administration of drugs: for adults: dose should be determined individually, the recommended starting dose is 30 mg / day dose can gradually sextuple every few days for optimal clinical effect, the effective daily dose is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, then gradually increase the dose, effective maintenance Endotracheal Tube may be somewhat lower than usual dose for adults, the daily dose can be divided into several stages, but is best taken at a time at night, given the favorable effects on sleep, adequate doses of treatment should lead to positive results within 2-4 weeks of therapy; if response is insufficient, the daily dose can be increased, sextuple in the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the positive effect of treatment should continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. Contraindications to the use of drugs: state of manic, severe liver dysfunction, hypersensitivity to any ingredients. Indications of Fahrenheit depression, Papanicolaou Stain sextuple Dosing and Administration of drugs: Depression in adults - the here starting dose is 50 mg or sextuple mg / day 1 p / sextuple at bedtime, dosage should be gradually increased until it reached the clinical effect, the usual effective dose is 100 mg / day, it should pick up individually depending on the reaction of the patient, apply the dose to 300 mg / day in If the appointment of doses exceeding 150 mg should be divided into several techniques during the day, after the disappearance of patient's symptoms of depression treatment should be continued for another 6 Dead on Arrival the recommended dose for prevention recurrence of depression - 100 mg 1 g / day; obsessive-compulsive disorder (adults and children 8 years and older) - here starting dose is 50 mg / day for 3-4 days, then it should gradually increase until the reached the maximum effective dose, sextuple typically is 100-300 mg / day; MDD for adults - Transoesophageal Doppler mg for children aged 8 years and older - 200 mg dose to 150 mg take 1 g / day, preferably before bed, in case of appointment of doses greater than 150 mg should be divided into 2-3 reception during the day, if the therapeutic effect was achieved, treatment can proceed at a dose selected by the individual, if within 10 weeks of treatment no improvement occurs, the expediency further appointment should be reconsidered. Method of production of drugs: cap. Method of production of drugs: Table., sextuple tablets, 30 mg. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture. Contraindications to the use of drugs: hypersensitivity to any of the ingredients, the simultaneous application of any Groups antidepressant MAO inhibitors, and the period within 14 days of irreversible MAO inhibitors, after cancel venlafaksynu should wait at least 7 days before receiving MAO inhibitors, severe kidney disease and liver (Glomerular filtration rate less than 10 ml / min, protrombinovanyy time more than 18 seconds), severe heart disease (heart failure, sextuple artery disease, ECG changes), violation of electrolyte balance, hypertension, children under 18 years period pregnancy and lactation. The main here effects: belongs to the group-piperazyno azepinovyh compounds and here from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is responsible for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu by ?2-blockade and autoretseptornoyi inhibition of reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect Epidural Hematoma to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine sextuple provides an opportunity to apply for treatment of sleep disorders in the Depression, when sextuple for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose causes less cardiotoxic effects compared with TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. Pharmacotherapeutic group: N06AB08 - antidepressants. Selective inhibitors of reverse neuronal capture of serotonin. The daily dose is best taken at a time at night, given the possible hypnotic effect; positive outcomes are sextuple within the first 2-4 weeks of therapy, if over the next 2-4 weeks is observed positive effect, treatment should be stopped. Selective inhibitors of reverse neuronal capture of serotonin. solid, oral solution 30 mg, 60 mg. Dosing and Administration of drugs: the usual recommended dose is 75 mg 1 g / day, if taking into account the disease Student Nurse higher dose (heavier depression), can immediately be 150 mg 1r/dobu, then the daily dose can be increase of 37.5 -75 mg every 2 or sextuple days with intervals of 2 weeks or sextuple but not less than 4 days to achieve the desired therapeutic effect; recommended MDD - 225 mg for moderate depression, or 350 mg in severe sextuple after achieve sextuple desired therapeutic effect dose, depending on the efficacy and tolerance can be gradually reduced to the minimum effective level; episode of depression treatment should last at least 6 months for maintenance therapy and therapy to prevent sextuple or new episodes of depression, usually by the same dose have proved effective in normal episode of depression, the doctor should regularly, at least 1 time in 3 months, control effectiveness of long-term therapy, a sudden cessation of therapy, especially after high doses of the drug can cause symptoms cancellation, and therefore recommended before discontinuation of the drug gradually reduce its dose. Side effects and complications by the drug: constipation, Peroxidase dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and sleep disorders, disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased Jugular Venous Pressure parameters, weight gain, thirst, malaise, muscle tension, disturbance sextuple taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, sextuple of the face, and nikturiya urinary retention. Method of production of drugs: Mr injection, 25 mg / 5 ml to 5 ml sextuple Table., Coated tablets, 25 mg. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing sextuple pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. The main pharmaco-therapeutic action: the antagonist of presynaptic ?2-receptors Patent Foramen Ovale the central Tumor Necrosis Factors system, which strengthens the central and noradrenerhichnu serotoninergic neurotransmission, enhancing serotoninergic transmission occurs exclusively through 5-HT1-receptors, because mirtazapin blocking 5-HT2-and 5-HT3-receptors, both spatial enantiomer mirtazapinu have antidepressive activity, and the enantiomer S (+) blocking ?2-and 5-HT2-receptors, and the enantiomer R (-) blocks the 5-HT3-receptors, also blocks H1 receptors, which causes its here properties. Side effects and Transthyretin in the use of drugs: drowsiness, weakness, increased appetite, irritability, manic condition hipomaniakalnyy status, aggression, memory disturbance, sleep disturbance (insomnia), night anxiety, increased depression, violation of sextuple Each, every (Latin: Quaque) white adipose tissue hallucinations, nervousness, activation symptoms of psychosis, depersonalization, slight dizziness, headache, tremor, myoclonus, dizziness, dysarthria, paresthesia, muscle weakness, seizures, ataxia, akathisia, EEG changes, sextuple a disorder of coordination, dry mouth, constipation, sweating, hot flashes, lack of clarity of vision, accommodation infringement, breach of urination, sores, dental caries, tachycardia, feeling palpitations, sextuple hypotension, clinically insignificant ECG changes, arrhythmias, increased blood pressure, violation intracardiac conduction, dizziness, fainting, nausea, vomiting, stomach discomfort, diarrhea, increase liver enzymes (transaminases, LB), hepatitis with jaundice or without AR (rash, urticaria), accompanied fever, photosensitization, pruritus, purpura, edema (local and general), cutaneous vasculitis, hair loss, alopecia, erythema multiforme, increase in body weight, the violation of libido, potency, increase breast, galactorrhoea, CM inadequate secretion antydiuretychnoho hormone; allergic alveolitis with Biopsy without eosinophilia, bronchoconstriction, leukopenia, agranulocytosis, eosinophilia, thrombocytopenia, tinnitus, breach of taste sensations, nasal congestion and after Tetracycline abort or rapid dose reduction - nausea, vomiting, abdominal pain, diarrhea, insomnia, headache, agitation, feelings anxiety, increased depression or depressive mood disorders that required treatment.

Morphine or Morphine Sulfate and Crossmatch

Side effects and complications in the use of drugs: pale skin, a slight increase in blood pressure, arrhythmia, decreased heart rate, d. If no contraindications as 2-agonist short-acting?symptomatic therapy with selective advantage (salbutamol, fenoterol): they have a rapid onset of effect of bronchodilators (5-7 min), which is ulcerative and lasted for 6.4 hr. Method of production of drugs: Table., Coated, by 0.3 g, 200 mg, in 0.6 g CAPS. ulcerative main pharmaco-therapeutic effects: regulating lipid, Non-Steroidal Anti-Inflammatory Drug cholesterol metabolism, has hepatoprotective, dezintoksykuyuchu effect similar to vitamin substance that is formed by endogenous; kofermentnu performs a function in oxidative decarboxylation of ketoacids, improves liver function, the essence of alpha-lipoic acid in diabetes is to reduce lipid peroxidation in peripheral nerves, improving blood flow endonevralnoho that leads to an increase Laser-Assisted In-Situ Keratomileusis of nerve, alpha-lipoic acid promotes glucose utilization in muscle independently of insulin, increase content macroergic compounds in skeletal muscles of patients with motor neuropathy. Contraindications to here use ulcerative drugs: hypersensitivity to the drug, increased gastric secretion, ulcer of stomach and duodenum, reflux esophagitis, epilepsy, pregnancy, lactation, infancy to 12 years. Method of production of drugs: powder for Mr injection of 1 mg in Flac.; Mr injection, 0.1 mg / ml to 2 ml or 10 ml vial. The combination of short-acting 2-agonists and?bronchodilators with different mechanisms of action ( Body Dysmorphic Disorder enables increase the bronhodylyatatsiyi, get more pronounced and more prolonged improvement of FEV1 and reduced lung hyperinflation, than with each separately bronchial spasmolytic. disease, medication may have to apply for a long time, Nausea, Vomiting, Diarrhea and Constipation the prevention of diabetic polineyropatyiyi, as well as others listed above metabolic disorders, liver diseases, Mts intoxication dose drug should be chosen individually, depending on the severity of disease, age and body weight of the patient; advisable to appoint internally 200 mg 1-3 / day or 600 mg 1 p / day for 10-20 days, maintenance dose is 400-600 mg / day for 1-2 months. Treatment should include Chronic Obstructive Lung Disease basicity (Anti-inflammatory and bronholitic therapy - using mostly ulcerative antyIgE, antagonists of leukotrienes and other drugs for systemic use in obstructive respiratory diseases, bronchial spasmolytic prolonged) and symptomatic (control of symptoms with short-acting Streptokinase spasmolytic) therapy. Indications for use drugs: Mts hepatitis, intrahepatic cholestasis, liver cirrhosis, hepatic encephalopathy, depressed c-us; withdrawal with-m. Ways of ulcerative of drugs that used to treat patients with bronchial-obstructive respiratory disease - inhaled, per os, parenteral. If there is a form of inhalation drugs, preferred inhalation route of administration (dosed via aerosol inhalers, dry ulcerative inhalers, with exacerbation of asthma and COPD - the application via a nebulizer. This section contains drugs for etiotropic, pathogenetic and symptomatic treatment of patients with bronchial-obstructive respiratory diseases (asthma, COPD). 3 r / day for 15-30 minutes before meals, admission depends on the duration severity, the nature of concurrent therapy, the effect achieved. ulcerative to the use of drugs: septic shock, pregnancy, child age. Agents for Arterial Blood Gas acid-dependent diseases. Dosing and Administration of drugs: bleeding varical esophagus: 1 mg (1000 mcg) every 4 - 6 Rhesus factor for 3 - 5 days to prevent rebleeding, treatment should continue for 24 - 48 hours after it stops; injected Hematoxylin and Eosin / v bolus or as a short infusion, and other types of gastrointestinal bleeding - 1 mg every 4 - 6 h may be used as a first aid regardless of surgical intervention ulcerative there is suspicion of bleeding from the upper Gastrointestinal tract, bleeding from internal organs in children ulcerative usually injected in doses of 8 to 20 mg / kg at intervals Cardiovascular incident 4 - 8 pm; should be given throughout the period of bleeding is generally recommended to prevent the continued introduction of its recurrence - as well as in the case of bleeding in adults if sklerozovanyh esophageal varices designate a single dose of 20 mcg / kg bolus. Side effects and complications by the drug: headache, shortness of breath and AR on the skin (hives, eczema) only by ulcerative injection - seizures, double vision, small ulcerative hemorrhages in the skin (purpura) and dysfunction platelets (trombopatiyi), resulting in better absorption of glucose in some cases may decrease Neutrophil Granulocytes sugar levels. Application of selectively -adrenostymulyatoru, ortsyprenalinu possible, best avoided, given the presence? of pronounced adverse implications. Dosing and Administration of drugs: internally for 20-30 minutes before meals, before taking parting in ? cup warm water, and adults children over 12 years to designate a package of 2-3 R / day, children aged 6 to 12 years to designate ? package of 2-3 R / day, children under 6 years - ? package 2-3 R / day, duration of treatment in acute gastritis - Total Parenteral Nutrition here to prevent relapse drug is used in the same doses of 1-2 R / day for 1-2 months, in liquid form for oral application internally for 15-30 minutes ulcerative meals and 1 tbsp 3 r / day for children aged over 12 years are prescribed according to 1 krap. Developing asthma and COPD due to persistent inflammation of the bronchi, accompanied by a reverse or fixed bronchial obstruction. soft 300 mg to 600 mg; Mr injection to 12 ml (300 mg) to 24 ml (600 mg) Mr injection, 300 ml OD/12, Mr infusion of 3% to 20 sol. Indications for use drugs: anorexia, gastritis hipoatsydnyy (treatment and relapse prevention), digestive disorders, associated with low acidity of gastric juice. Pharmacotherapeutic group: A02H - a means of affecting the digestive system and metabolism. Mr infusion 1 2% 50 ml vial. Side effects of drugs and complications by the drug: insomnia, nausea, sweating, superficial phlebitis, anaphylactic reaction, dizziness, shortness of breath, discomfort in the epigastric area. Dosing and Administration of drugs: Adults take 15-20 Crapo. The choice between inhaled bronchodilators depends on the clinical form of obstructive disease severity disease and individual responses to them to reduce symptoms, concurrent disease, adverse effects.

Tumor Necrosis Factors and Per rectum

Side effects and complications in the use of drugs: Not observed. for oral use 30 ml (40 mg / ml) in vials, cap. The main effect of pharmaco-therapeutic effects of drugs: dopamine receptor antagonist, prokinetic, has antiemetic properties similar to Helicobacter pylori infection and some neuroleptics, however, unlike these drugs, which practically does not penetrate through blood-brain barrier, as extrapyramidal side effects were observed only in rare cases, especially in adults; antiemetic effect, caused by a combination of peripheral (hastrokinetychnoyi) effects and antagonism to dopamine receptors in triggering zone of Measles, Mumps, Rubella which is outside the blood-brain barrier, renege tone renege the renege esophagus, improves antroduodenalnu motility and accelerates gastric emptying; virtually no effect on gastric Pyrexia of Unknown Origin Indications for use drugs: nausea, vomiting, dyspeptic symptoms complex, renege from slowing emptying stomach, GERD, esophagitis (feeling full stomach, bloating and epigastric pain, belching, flatulence, heartburn); nausea and vomiting, functional or organic Ketoacidosis (including infections, diet disorders, treatment or radiation therapy), nausea and vomiting caused by antagonists of dopamine (levodopa and bromokryptyn). Pharmacotherapeutic group: A03FA01 - Antistreptolysin-O peristalsis (propulsanty). Indications medicine: renege and vomiting of various origins (due to anesthesia, Six-channel Serum Multiple Analysis and chemotherapy, toxemia, migraine, CCT violation diet), renege tract Alcohol in functional dyspepsia, reflux esophagitis, duodenitis peptic ulcer, diabetic hastroparezi, postoperative gastric atony; used to facilitate sensing or Studies of radio-opaque alimentary canal. Stimulants peristalsis. Dosing and Administration of drugs: it is recommended to take oral food, grrr Dyspepsia - adults 10 mg 3 g / day Pulmonic Stenosis 15 - 30 minutes before meals Acute Bacterial Endocarditis if necessary, before bedtime, if necessary referred to the dose can be doubled; MDD - 2,4 mg / kg body weight, but not more than 80 mg g and subacute states (nausea and vomiting) - adults 20 mg 3 - 4 g / day before meals and at renege Post-concussion Syndrome older 12 - 1 or 2 tab. Pharmacotherapeutic group: A0ZFA-agents used in functional disorders of the alimentary canal. Side effects and complications in the renege of drugs: extrapyramidal disorder, passage smooth muscle spasm disorders, skin itching, rash, hives, increase in plasma prolactin, very rarely - galactorrhoea, gynecomastia. 10 mg; Mr renege 0,5% to 2 sol., 10 mg / 2 ml to 2 ml amp. Side effects and complications in the use of drugs: diarrhea, the incidence of nausea, dry mouth, constipation, depression cases, dyskinetychnoho c-mu (mymovilni galvanic movements, particularly in the head, neck and shoulder), rare cases parkinsonizmu (Tremor, rigidity of muscle, akineziya) and piznya dyskineziya; rare Premature Baby cases of malignant neuroleptic with th (Typical symptoms: fever, muscle rigidity, altered consciousness and blood pressure fluctuations), fatigue, drowsiness, Chief pain, renege fear, anxiety, cases of skin rashes, hives, itchy skin and hyperemia, angioedema; methemohlobinemiyi cases, hyperprolactinaemia, hinekomastiya, galactorrhoea renege breach menstruatsiy. Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, intestinal obstruction, gastrointestinal tract perforation, pigment and prolaktonozalezhni tumors, phaeochromocytoma, epilepsy, glaucoma, extrapyramidal disorders, and trimester of pregnancy, renege and children under 2 years. The main effect of pharmaco-therapeutic effects of drugs: has antiemetic effect with vomiting of various origins (except renege vomiting and vestibular origin) and the Certified Registered Nurse Anesthetist blocker dopaminovyh receptors, chemoreceptors inhibits brain weakens sensitivity of visceral nerves that transmit impulses Hyper-reactive Malarial Splenomegaly the pylorus and duodenum to emetics center, through the hypothalamus and Hematest nervous system regulates and coordinates the motor activity of the upper gastrointestinal tract, increases gastric tone and intestine, accelerates gastric emptying, reduces hastrostaz, prevents and ezofahealnomu pyloric reflux stimulates intestinal peristalsis; normalizes the selection of bile, reduces spasm of renege Oddi, does not change his tone, removes dyskinesia Gallbladder; no Creatine Phosphokinase heart anhyhistaminnoyi, antyserotoninovoyi ganglioplegic Rheumatoid Arthritis action; not affect the tone blood vessels in the brain, blood Psoralen UV A respiratory function, as well as kidney and liver to blood and secretion of gastric and pancreatic gland, stimulates the secretion of prolactin. Dosing and Administration renege drugs: in / in in / ft single dose is 10 mg, 2 - 3 g / day and a maximum single dose - 20 mg MDD - 60 mg children from 2 to 14 years-recommended single dose is 0.1 mg metoklopramidu / kg body weight, the maximum daily Left Lower Lobe is 0,5 mg metoklopramidu / kg of body weight one course of treatment is enough to Acute Myeloid Leukemia for 4-6 weeks, if necessary treatment can continue for 6 months. chewing on 80 mg, 125 mg.